Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.

Albach, Fredrik N; Burmester, Gerd R; Biesen, Robert

Albach, Fredrik N; Burmester, Gerd R; Biesen, Robert.

Albach FN; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Biesen R; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany robert.biesen@charite.de.

Ann Rheum Dis ; 80(10): 1361-1362, 2021 10.

Article in English | MEDLINE | ID: covidwho-1282055

Subject(s)

Arthritis, Rheumatoid/immunology; COVID-19 Vaccines/immunology; COVID-19/prevention & control; Immunocompromised Host/immunology; Antibodies, Neutralizing/blood; Antibodies, Neutralizing/immunology; Antibodies, Viral/blood; Antibodies, Viral/immunology; Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/complications; BNT162 Vaccine; Heterocyclic Compounds, 3-Ring/therapeutic use; Humans; Immunization, Secondary; Immunogenicity, Vaccine/drug effects; Immunogenicity, Vaccine/immunology; Male; Methotrexate/therapeutic use; Middle Aged; Polycythemia Vera/complications; SARS-CoV-2; Vasculitis, Leukocytoclastic, Cutaneous/complications

Keywords

COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Immunocompromised Host / COVID-19 Vaccines / COVID-19 Type of study: Case report Topics: Long Covid / Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220834

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google